Clapp Carmen, Aranda Jorge, González Carmen, Jeziorski Michael C, Martínez de la Escalera Gonzalo
Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus UNAM-Juriquilla, Querétaro 76230, México.
Trends Endocrinol Metab. 2006 Oct;17(8):301-7. doi: 10.1016/j.tem.2006.08.002. Epub 2006 Aug 23.
Vasoinhibins are a family of peptides derived from prolactin, growth hormone and placental lactogen that act on endothelial cells to suppress vasodilation and angiogenesis and to promote apoptosis-mediated vascular regression. Some of the pathways by which vasoinhibins act have now been defined, and recent developments indicate that endogenous vasoinhibins exert tonic and essential actions on blood vessel growth, dilation and regression in vivo. By studying the pathways that can generate vasoinhibins, and the nature of their receptors and key biological mediators, it should be possible to clarify the role of vasoinhibins in controlling vascular function in health and disease.
血管抑制素是一类由催乳素、生长激素和胎盘催乳素衍生而来的肽,作用于内皮细胞以抑制血管舒张和血管生成,并促进凋亡介导的血管消退。血管抑制素发挥作用的一些途径现已明确,最近的研究进展表明,内源性血管抑制素在体内对血管生长、舒张和消退发挥着持续性的重要作用。通过研究能够产生血管抑制素的途径及其受体和关键生物介质的性质,应该能够阐明血管抑制素在健康和疾病状态下控制血管功能中的作用。